HD-OPM Archive
Topics › Supplements & vitamins

GLYLO's mouse lifespan benefit may stem from calorie restriction, per a critical analysis

Louis Nervegna · Dec 03, 2025 · ♥ 2 reactions · 5 comments · original Facebook post
Supplements & vitaminsAging & longevity
AI summary & key facts

Louis shares a Substack critique of the glycation-focused supplement GLYLO, which questions the mouse lifespan data, the role of reduced food intake and differences between the research and consumer formulas. His comment is that even if benefits come from inadvertent calorie restriction, that is still significant, as with GLP-1 drugs.

Even if the benefits are coming mainly from inadvertent calorie restriction (CR), that is still a big deal.

Look at all of the ancillary benefits of the new GLP-1 agonist drugs in humans. Most of these ancillary benefits are probably coming from the CR that these drugs induce.

Also see this previous post on this study: ↪ Gly-Low glycation-lowering cocktail extended lifespan in mice

#glyloHD #methylglyoxalHD #agesHD #kapahiHD #buckHD #agingHD #longevityHD #glycationHD #nicotinamideHD #lipoicacidHD #vitaminb1HD #vitaminb6HD #piperineHD #bvitaminsHD #vitaminb3HD

Research cited

I’ve posted a new article on my Substack: a critical analysis of GLYLO/Gly-Low, the glycation-focused supplement developed from work at the Buck Institute.

The article delves into the mouse lifespan data, the role of reduced food intake, and why the research and consumer formulas differ.

Read here:

← newer: Finland's North Karelia Project: less saturated fat, CHD deaolder: Framingham data link a high omega-3 index to about 5 more ye →